The statistic displays the quarterly share of Celltrion's Remsima in the European market from the first quarter of 2015 to the second quarter of 2018. As of Q2 2018, the Remsima products from South Korean biopharmaceutical company Celltrion took up around 54 percent within the European market, increased from 53 percent in the previous quarter.
Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Members of EFPIA's pharmaceutical R&D spending 1990-2022
- Premium Statistic Revenue of GC Pharma 2015-2022
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Revenue of Samsung Biologics 2015-2022
- Premium Statistic Top global companies by orphan drug revenues 2022
- Premium Statistic Merck & Co.'s top-selling drugs 2022
About the region
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic Net income Yuhan 2015-2022
Selected statistics
10
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2022-2028
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada by age 2021
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Premium Statistic Pharma market value in Argentina 2008-2021
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Sold packaging units of phytopharmaceuticals in Germany in 2020, by sales channel
Related statistics
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic OTC drug products production value South Korea 2010-2021
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Pfizer's ad spending 2008-2022
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Pfizer's ad spending 2008-2022
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
Mirae Asset. (December 5, 2018). Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018 [Graph]. In Statista. Retrieved December 05, 2023, from https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/
Mirae Asset. "Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018 ." Chart. December 5, 2018. Statista. Accessed December 05, 2023. https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/
Mirae Asset. (2018). Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018 . Statista. Statista Inc.. Accessed: December 05, 2023. https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/
Mirae Asset. "Quarterly Share of Celltrion's Remsima in The European Market from 1st Quarter 2015 to 2nd Quarter 2018 ." Statista, Statista Inc., 5 Dec 2018, https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/
Mirae Asset, Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018 Statista, https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/ (last visited December 05, 2023)
Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018 [Graph], Mirae Asset, December 5, 2018. [Online]. Available: https://www.statista.com/statistics/1000627/south-korea-celltrion-remsima-market-share-in-europe/